Correction: Chronic pain and psychedelics: a review and proposed mechanism of action
Regional Anesthesia & Pain Medicine August 22, 2022 correction DOI: 10.1136/rapm-2020-101273corr1 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review |
|---|---|
| Key findings | Proposes that psychedelics may reduce chronic pain by acting on serotonin receptors and inducing neuroplasticity, potentially disrupting maladaptive pain circuits. The authors argue that this mechanism, combined with psychotherapy, could offer a novel treatment approach, but call for more clinical research. |
Abstract
Castellanos JP, Woolley C, Bruno KA, et al . Chronic pain and psychedelics: a review and proposed mechanism of action. Reg Anesth Pain Med 2020;45:486–94. doi:10.1136/rapm-2020–101273. This article has been corrected due to multiple referencing errors. Some references had become misordered